Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging
- 1 January 2004
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 43 (1) , 27-34
- https://doi.org/10.1016/j.jacc.2003.08.031
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Magnetic Resonance Contrast Enhancement of Iatrogenic Septal Myocardial Infarction in Hypertrophic CardiomyopathyCirculation, 2002
- Anatomy of the First Septal Perforating Artery: A Study With Implications for Ablation Therapy for Hypertrophic CardiomyopathyMayo Clinic Proceedings, 2001
- Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-upJournal of the American College of Cardiology, 2000
- Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patientsHeart, 2000
- Nonsurgical Septal Reduction for Hypertrophic Obstructive CardiomyopathyCirculation, 1997
- Myocardial Gd-DTPA Kinetics Determine MRI Contrast Enhancement and Reflect the Extent and Severity of Myocardial Injury After Acute Reperfused InfarctionCirculation, 1996
- Extent of Clinical Improvement After Surgical Treatment of Hypertrophic Obstructive CardiomyopathyCirculation, 1996
- Hypertrophic CardiomyopathyCirculation, 1995
- Hypertrophic obstructive cardiomyopathy. Initial results and long-term follow-up after Morrow septal myectomy.Circulation, 1994
- Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysisThe American Journal of Cardiology, 1990